Skip to content
Ablacon
Ablacon
Better AF treatment through AI.
  • Home
  • News
  • Publications
  • Team
  • Contact
  • Privacy Policy

Electrographic Flow (EGF)

Our technology visualizes in real-time what is going on in the heart. We compute the electrographic flow which allows to treat atrial fibrillation faster, more precisely and more reliably.

Learn more

Ablamap® is CE Marked and commercially available in the EU. Ablamap® is not commercially available in the United States and limited to research use.
Copyright © 2021 Ablacon, Inc.